HEXIMA LIMITED. - Announcements

0.00%

1.3¢

Market Cap $2.171M

Healthcare Biotechnology

Hexima Limited is an Australia-based company. The Company is exploring opportunities for... Hexima Limited is an Australia-based company. The Company is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.More

BPH Energy (ASX:BPH) continues court battle while eastern states energy crisis worsens

Announcements

Filter Results

All Price Sensitive Only

HXL	Appendix 4E & Preliminary Final Report	PRICE SENSITIVE	30/08/22	419.23KB	Share
HXL	Becoming a substantial holder		24/08/22	114.65KB	Share
HXL	Ceasing to be a substantial holder		24/08/22	46.61KB	Share
HXL	Becoming a substantial holder		19/08/22	112.01KB	Share
HXL	Notification of cessation of securities - HXL		05/08/22	25.4KB	Share
HXL	Michael Aldridge Resigns as CEO, Remains as Director	PRICE SENSITIVE	02/08/22	112.54KB	Share
HXL	Quarterly Activities Report and Appendix 4C - Jun-22 Qtr	PRICE SENSITIVE	21/07/22	1.24MB	Share
HXL	Phase II Results	PRICE SENSITIVE	11/07/22	221.69KB	Share
HXL	Phase II Preliminary Results	PRICE SENSITIVE	24/06/22	168.98KB	Share
HXL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/04/22	2.78MB	Share
HXL	ShareCafe Presentation		29/04/22	1.22MB	Share
HXL	Notification regarding unquoted securities - HXL		28/04/22	29.74KB	Share
HXL	Notification of cessation of securities - HXL		07/04/22	22.57KB	Share
HXL	Investor Webinar on Today		05/04/22	2.68MB	Share
HXL	Change of Director's Interest Notice-Nicole van der Weerden		01/04/22	181.94KB	Share
HXL	Pezadeftide Mode of Action Presentation Released		28/03/22	185.33KB	Share
HXL	Notice of change of interests of substantial holder		22/03/22	297.6KB	Share
HXL	Pezadeftide MOA Presented at AAD Annual Meeting		22/03/22	194.81KB	Share
HXL	Notice of change of interests of substantial holder		09/03/22	293.19KB	Share
HXL	Change of Director's Interest Notice - Dr van der Weerden		28/02/22	175.21KB	Share
HXL	Notification of cessation of securities - HXL		24/02/22	22.58KB	Share
HXL	Notice under Section 708A(5)(e) of Corporations Act		24/02/22	201.53KB	Share
HXL	Application for quotation of securities - HXL		24/02/22	32.92KB	Share
HXL	Appendix 4D and Interim Financial Statements	PRICE SENSITIVE	24/02/22	931.73KB	Share
HXL	Notification regarding unquoted securities - HXL		08/02/22	28.61KB	Share
HXL	Statement Pursuant to ASX Listing Rule 4.7C.2	PRICE SENSITIVE	03/02/22	233.88KB	Share
HXL	Notice under Section 708A(5)(e) of Corporations Act		01/02/22	208.98KB	Share
HXL	Application for quotation of securities - HXL		01/02/22	27.37KB	Share
HXL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/22	7.34MB	Share
HXL	Edison Global Healthcare 2022		24/01/22	166.43KB	Share
HXL	Phillip Rose Appointed Chief Commercial Officer		04/01/22	184.91KB	Share
HXL	Notification of cessation of securities - HXL		24/12/21	23.08KB	Share
HXL	Notification regarding unquoted securities - HXL		24/12/21	28.89KB	Share
HXL	Change of Director's Interest Notice - Mr Steven Skala		14/12/21	178KB	Share
HXL	Change of Director's Interest Notice - Mr Scott Robertson		14/12/21	172.08KB	Share
HXL	Change of Director's Interest Notice - Dr van der Weerden		14/12/21	172.58KB	Share
HXL	Change of Director's Interest Notice - Mr Michael Aldridge		14/12/21	171.85KB	Share
HXL	Change of Director's Interest Notice - Mr Justin Yap		14/12/21	172.06KB	Share
HXL	Change of Director's Interest Notice-Professor Jonathan West		14/12/21	175.72KB	Share
HXL	Change of Director's Interest Notice - Mr Jason (Jake) Nunn		14/12/21	174.77KB	Share
HXL	Notification regarding unquoted securities - HXL		13/12/21	32.63KB	Share
HXL	Notice under Section 708A(5)(e) of Corporations Act		09/12/21	137.29KB	Share
HXL	Application for quotation of securities - HXL		08/12/21	23.38KB	Share
HXL	Final Director's Interest Notice - Marilyn Anderson		06/12/21	202.81KB	Share
HXL	Results of Meeting		02/12/21	193.36KB	Share
HXL	CEO's Presentation		02/12/21	2.12MB	Share
HXL	Marilyn Anderson Steps Down From Board		02/12/21	126.21KB	Share
HXL	Shari Lipner Appointed to SAB		02/12/21	127.89KB	Share
HXL	Nancy Sacco Appointed Chief Development Officer		02/12/21	183.71KB	Share
HXL	Application for quotation of securities - HXL		26/11/21	25.06KB	Share
HXL	$1 Million Raised via Share Purchase Plan	PRICE SENSITIVE	26/11/21	156.51KB	Share
HXL	Jobkeeper Payments Notice		12/11/21	152.58KB	Share
HXL	Share Purchase Plan Opens and Offer Booklet		08/11/21	785.05KB	Share
HXL	Notice under Section 708A(5)(e) of Corporations Act		05/11/21	137.48KB	Share
HXL	Application for quotation of securities - HXL		04/11/21	23.38KB	Share
HXL	Online Meeting Guide		01/11/21	1.64MB	Share
HXL	Notice of Annual General Meeting/Proxy Form		01/11/21	666.36KB	Share
HXL	Proposed issue of securities - HXL		01/11/21	35.3KB	Share
HXL	Capital Raising Presentation	PRICE SENSITIVE	01/11/21	1.59MB	Share
HXL	Proposed issue of securities - HXL		01/11/21	24.81KB	Share
HXL	Completion of $10 Million Institutional Placement	PRICE SENSITIVE	01/11/21	197.59KB	Share
HXL	Trading Halt	PRICE SENSITIVE	28/10/21	476.31KB	Share
HXL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/10/21	3.68MB	Share
HXL	AusBiotech Invest Presentation		26/10/21	1.28MB	Share
HXL	Presenting at AusBiotech		13/10/21	114.6KB	Share
HXL	Appointment of Company Secretary		06/10/21	138.1KB	Share
HXL	Application for quotation of securities - HXL		27/09/21	25.11KB	Share
HXL	Presenting at Switzer Small & Micro-Cap Virtual Investor Day		27/09/21	1.3MB	Share
HXL	ACCESS CHINA Biotech Forum		24/09/21	1.45MB	Share
HXL	Restricted Securities to be Released from Escrow		17/09/21	149.15KB	Share
HXL	Notification regarding unquoted securities - HXL		16/09/21	28.98KB	Share
HXL	ASX Small and Mid-Cap Conference Presentation		14/09/21	1.18MB	Share
HXL	Review of FY21 - Investor Webinar		08/09/21	2.12MB	Share
HXL	Corporate Governance Statement		07/09/21	222.36KB	Share
HXL	Review of FY21 - Investor Webinar		03/09/21	172.72KB	Share
HXL	Investor Webinar on Today	PRICE SENSITIVE	02/09/21	2.95MB	Share
HXL	Appendix 3X		01/09/21	188.19KB	Share
HXL	Appointment of Jake Nunn as Non-Executive Director		01/09/21	186.81KB	Share
HXL	Annual Report 2021		27/08/21	1.79MB	Share
HXL	Appendix 4E	PRICE SENSITIVE	27/08/21	141.48KB	Share
HXL	Appendix 4G		27/08/21	235.38KB	Share
HXL	China Patent for Pezadeftide Granted	PRICE SENSITIVE	24/08/21	222.34KB	Share
HXL	Design Patent for Pezadeftide Commercial Packaging		19/08/21	207.59KB	Share
HXL	APMA presentation and investor webinar	PRICE SENSITIVE	29/07/21	1.01MB	Share
HXL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	28/07/21	4.49MB	Share
HXL	Completion of enrolment in Phase IIb Clinical Trial		26/07/21	206.4KB	Share
HXL	Presenting Clinical Data at APMA and Investor Webinar		15/07/21	183.75KB	Share
HXL	Grant of European Patent over Pezadeftide		14/07/21	201.44KB	Share
HXL	Media Interview and Investor Presentation		30/06/21	196.01KB	Share
HXL	ShareCafe Presentation		25/05/21	1.8MB	Share
HXL	Hexima receives INN designation for HXP124		20/05/21	197.93KB	Share
HXL	Grant of HXP124 Patent		12/05/21	185.54KB	Share
HXL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	27/04/21	6.67MB	Share
HXL	Hexima to Present at APMA		26/04/21	226.42KB	Share
HXL	R&D Webinar on Today		25/03/21	4.03MB	Share
HXL	SAB Formation and R&D Video Conference		09/03/21	257.33KB	Share
HXL	Half Year Report and Accounts	PRICE SENSITIVE	25/02/21	778.65KB	Share
HXL	Statement pursuant to ASX listing rule 4.7C.2		08/02/21	177.63KB	Share
HXL	Transcript of Investor 4th Quarter Call		29/01/21	137.76KB	Share
HXL	Quarterly Activity Report	PRICE SENSITIVE	29/01/21	6.87MB	Share

HXL Appendix 4E & Preliminary Final Report
30/08/22	PRICE SENSITIVE	419.23KB	Share
HXL Becoming a substantial holder
24/08/22		114.65KB	Share
HXL Ceasing to be a substantial holder
24/08/22		46.61KB	Share
HXL Becoming a substantial holder
19/08/22		112.01KB	Share
HXL Notification of cessation of securities - HXL
05/08/22		25.4KB	Share
HXL Michael Aldridge Resigns as CEO, Remains as Director
02/08/22	PRICE SENSITIVE	112.54KB	Share
HXL Quarterly Activities Report and Appendix 4C - Jun-22 Qtr
21/07/22	PRICE SENSITIVE	1.24MB	Share
HXL Phase II Results
11/07/22	PRICE SENSITIVE	221.69KB	Share
HXL Phase II Preliminary Results
24/06/22	PRICE SENSITIVE	168.98KB	Share
HXL Quarterly Activities Report and Appendix 4C
29/04/22	PRICE SENSITIVE	2.78MB	Share
HXL ShareCafe Presentation
29/04/22		1.22MB	Share
HXL Notification regarding unquoted securities - HXL
28/04/22		29.74KB	Share
HXL Notification of cessation of securities - HXL
07/04/22		22.57KB	Share
HXL Investor Webinar on Today
05/04/22		2.68MB	Share
HXL Change of Director's Interest Notice-Nicole van der Weerden
01/04/22		181.94KB	Share
HXL Pezadeftide Mode of Action Presentation Released
28/03/22		185.33KB	Share
HXL Notice of change of interests of substantial holder
22/03/22		297.6KB	Share
HXL Pezadeftide MOA Presented at AAD Annual Meeting
22/03/22		194.81KB	Share
HXL Notice of change of interests of substantial holder
09/03/22		293.19KB	Share
HXL Change of Director's Interest Notice - Dr van der Weerden
28/02/22		175.21KB	Share
HXL Notification of cessation of securities - HXL
24/02/22		22.58KB	Share
HXL Notice under Section 708A(5)(e) of Corporations Act
24/02/22		201.53KB	Share
HXL Application for quotation of securities - HXL
24/02/22		32.92KB	Share
HXL Appendix 4D and Interim Financial Statements
24/02/22	PRICE SENSITIVE	931.73KB	Share
HXL Notification regarding unquoted securities - HXL
08/02/22		28.61KB	Share
HXL Statement Pursuant to ASX Listing Rule 4.7C.2
03/02/22	PRICE SENSITIVE	233.88KB	Share
HXL Notice under Section 708A(5)(e) of Corporations Act
01/02/22		208.98KB	Share
HXL Application for quotation of securities - HXL
01/02/22		27.37KB	Share
HXL Quarterly Activities Report and Appendix 4C
31/01/22	PRICE SENSITIVE	7.34MB	Share
HXL Edison Global Healthcare 2022
24/01/22		166.43KB	Share
HXL Phillip Rose Appointed Chief Commercial Officer
04/01/22		184.91KB	Share
HXL Notification of cessation of securities - HXL
24/12/21		23.08KB	Share
HXL Notification regarding unquoted securities - HXL
24/12/21		28.89KB	Share
HXL Change of Director's Interest Notice - Mr Steven Skala
14/12/21		178KB	Share
HXL Change of Director's Interest Notice - Mr Scott Robertson
14/12/21		172.08KB	Share
HXL Change of Director's Interest Notice - Dr van der Weerden
14/12/21		172.58KB	Share
HXL Change of Director's Interest Notice - Mr Michael Aldridge
14/12/21		171.85KB	Share
HXL Change of Director's Interest Notice - Mr Justin Yap
14/12/21		172.06KB	Share
HXL Change of Director's Interest Notice-Professor Jonathan West
14/12/21		175.72KB	Share
HXL Change of Director's Interest Notice - Mr Jason (Jake) Nunn
14/12/21		174.77KB	Share
HXL Notification regarding unquoted securities - HXL
13/12/21		32.63KB	Share
HXL Notice under Section 708A(5)(e) of Corporations Act
09/12/21		137.29KB	Share
HXL Application for quotation of securities - HXL
08/12/21		23.38KB	Share
HXL Final Director's Interest Notice - Marilyn Anderson
06/12/21		202.81KB	Share
HXL Results of Meeting
02/12/21		193.36KB	Share
HXL CEO's Presentation
02/12/21		2.12MB	Share
HXL Marilyn Anderson Steps Down From Board
02/12/21		126.21KB	Share
HXL Shari Lipner Appointed to SAB
02/12/21		127.89KB	Share
HXL Nancy Sacco Appointed Chief Development Officer
02/12/21		183.71KB	Share
HXL Application for quotation of securities - HXL
26/11/21		25.06KB	Share
HXL $1 Million Raised via Share Purchase Plan
26/11/21	PRICE SENSITIVE	156.51KB	Share
HXL Jobkeeper Payments Notice
12/11/21		152.58KB	Share
HXL Share Purchase Plan Opens and Offer Booklet
08/11/21		785.05KB	Share
HXL Notice under Section 708A(5)(e) of Corporations Act
05/11/21		137.48KB	Share
HXL Application for quotation of securities - HXL
04/11/21		23.38KB	Share
HXL Online Meeting Guide
01/11/21		1.64MB	Share
HXL Notice of Annual General Meeting/Proxy Form
01/11/21		666.36KB	Share
HXL Proposed issue of securities - HXL
01/11/21		35.3KB	Share
HXL Capital Raising Presentation
01/11/21	PRICE SENSITIVE	1.59MB	Share
HXL Proposed issue of securities - HXL
01/11/21		24.81KB	Share
HXL Completion of $10 Million Institutional Placement
01/11/21	PRICE SENSITIVE	197.59KB	Share
HXL Trading Halt
28/10/21	PRICE SENSITIVE	476.31KB	Share
HXL Quarterly Activities Report and Appendix 4C
28/10/21	PRICE SENSITIVE	3.68MB	Share
HXL AusBiotech Invest Presentation
26/10/21		1.28MB	Share
HXL Presenting at AusBiotech
13/10/21		114.6KB	Share
HXL Appointment of Company Secretary
06/10/21		138.1KB	Share
HXL Application for quotation of securities - HXL
27/09/21		25.11KB	Share
HXL Presenting at Switzer Small & Micro-Cap Virtual Investor Day
27/09/21		1.3MB	Share
HXL ACCESS CHINA Biotech Forum
24/09/21		1.45MB	Share
HXL Restricted Securities to be Released from Escrow
17/09/21		149.15KB	Share
HXL Notification regarding unquoted securities - HXL
16/09/21		28.98KB	Share
HXL ASX Small and Mid-Cap Conference Presentation
14/09/21		1.18MB	Share
HXL Review of FY21 - Investor Webinar
08/09/21		2.12MB	Share
HXL Corporate Governance Statement
07/09/21		222.36KB	Share
HXL Review of FY21 - Investor Webinar
03/09/21		172.72KB	Share
HXL Investor Webinar on Today
02/09/21	PRICE SENSITIVE	2.95MB	Share
HXL Appendix 3X
01/09/21		188.19KB	Share
HXL Appointment of Jake Nunn as Non-Executive Director
01/09/21		186.81KB	Share
HXL Annual Report 2021
27/08/21		1.79MB	Share
HXL Appendix 4E
27/08/21	PRICE SENSITIVE	141.48KB	Share
HXL Appendix 4G
27/08/21		235.38KB	Share
HXL China Patent for Pezadeftide Granted
24/08/21	PRICE SENSITIVE	222.34KB	Share
HXL Design Patent for Pezadeftide Commercial Packaging
19/08/21		207.59KB	Share
HXL APMA presentation and investor webinar
29/07/21	PRICE SENSITIVE	1.01MB	Share
HXL Quarterly Activities Report and Appendix 4C
28/07/21	PRICE SENSITIVE	4.49MB	Share
HXL Completion of enrolment in Phase IIb Clinical Trial
26/07/21		206.4KB	Share
HXL Presenting Clinical Data at APMA and Investor Webinar
15/07/21		183.75KB	Share
HXL Grant of European Patent over Pezadeftide
14/07/21		201.44KB	Share
HXL Media Interview and Investor Presentation
30/06/21		196.01KB	Share
HXL ShareCafe Presentation
25/05/21		1.8MB	Share
HXL Hexima receives INN designation for HXP124
20/05/21		197.93KB	Share
HXL Grant of HXP124 Patent
12/05/21		185.54KB	Share
HXL Quarterly Activities Report and Appendix 4C
27/04/21	PRICE SENSITIVE	6.67MB	Share
HXL Hexima to Present at APMA
26/04/21		226.42KB	Share
HXL R&D Webinar on Today
25/03/21		4.03MB	Share
HXL SAB Formation and R&D Video Conference
09/03/21		257.33KB	Share
HXL Half Year Report and Accounts
25/02/21	PRICE SENSITIVE	778.65KB	Share
HXL Statement pursuant to ASX listing rule 4.7C.2
08/02/21		177.63KB	Share
HXL Transcript of Investor 4th Quarter Call
29/01/21		137.76KB	Share
HXL Quarterly Activity Report
29/01/21	PRICE SENSITIVE	6.87MB	Share

REFRESH

First 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.3¢		Change 0.000(0.00%)		Mkt cap ! $2.171M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

HXL (ASX) Chart

Day chart unavailable

HEXIMA LIMITED. - Announcements

Announcements

Top Stories